Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0A8JB
|
|||
| Former ID |
DNCL003298
|
|||
| Drug Name |
VAX-125
|
|||
| Indication | Human immunodeficiency virus infection [ICD-11: 1C62] | Phase 2 | [1] | |
| Influenza A virus infection [ICD-11: 1E30] | Phase 2 | [1] | ||
| Company |
VaxInnate
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00966238) Safety and Immunogenicity of VAX125 Influenza Vaccine in Community-living Adults >= 65 Years of Age. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.